Similar articles

• The impact of suppressing the renin-angiotensin system on atrial fibrillation.

  Kalus JS, Coleman CI, White CM. Kalus JS, et al. J Clin Pharmacol. 2006 Jan;46(1):21-8. doi: 10.1177/0091270005283284. J Clin Pharmacol. 2006. PMID: 16397280
• Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation.

  Baker WL, White CM. Baker WL, et al. Conn Med. 2007 Apr;71(4):205-9. Conn Med. 2007. PMID: 17487005 No abstract available.
• [Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker].

  Goette A. Goette A. Dtsch Med Wochenschr. 2006 Aug 25;131(34-35 Suppl 4):S103-7. doi: 10.1055/s-2006-949185. Dtsch Med Wochenschr. 2006. PMID: 16921445 Review. German. No abstract available.
• [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].

  Dabrowski R, Szwed H. Dabrowski R, et al. Kardiol Pol. 2007 Apr;65(4):440-5. Kardiol Pol. 2007. PMID: 17530565 Review. Polish. No abstract available.
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.

  Huang G, Xu JB, Liu JX, He Y, Nie XL, Li Q, Hu YM, Zhao SQ, Wang M, Zhang WY, Liu XR, Wu T, Arkin A, Zhang TJ. Huang G, et al. Eur J Clin Invest. 2011 Jul;41(7):719-33. doi: 10.1111/j.1365-2362.2010.02460.x. Epub 2011 Jan 20. Eur J Clin Invest. 2011. PMID: 21250983 Review.